This event has ended. Visit the official site or create your own event on Sched.


Jennifer Lentz

Eli Lilly and Company
Consultant, Global Informed Business Lead
Jennifer Lentz has been the Global Informed Consent Business Lead at Eli Lilly and Company for the last 4 years. She has been involved in consent projects with Clinical Trials Transformation Initiative, Transcelerate, and Innovative Medicines Initiatives. Prior to joining Lilly, Jennifer worked as a study monitor, study coordinator, disease field investigator, and lab researcher. She became interested in informed consent during her involvement as a pediatric research subject.